by McDermott + Bull | Sep 20, 2021 | Engagement Announcement, Ken Dropiewski, Quyen Doan
McDermott + Bull has been engaged to lead the search of Miromatrix Medical, Inc.’s next Vice President of Cellular Manufacturing and Technical Operations. This search will be led by McDermott + Bull Managing Partner Ken Dropiewski and Senior Executive Recruiter Quyen...
by McDermott + Bull | Sep 7, 2021 | Ken Dropiewski, White Paper
THE GREAT RESIGNATION: WHAT THE FUTURE HOLDS FOR TODAY’S JOB MARKET We hear it day in and day out — it’s so hard to find talent in this market! Oftentimes, the concept of finding “the perfect fit” stands in the way of a company making the best hiring decision, and not...
by McDermott + Bull | Sep 2, 2021 | Investor Insights, Ken Dropiewski
Check out McDermott + Bull Managing Director Ken Dropiewski’s series, Investor Insights in Life Sciences + MedTech, where he profiles some of the top investment professionals in this space. Stay tuned for more to...
by McDermott + Bull | Aug 30, 2021 | Ken Dropiewski, Placement Announcement
McDermott + Bull has successfully placed John Barry, Ph.D. as the Vice President of Research + Development at Miromatrix Medical, Inc. John will be responsible for the technical development of the organization’s whole organ programs and will work closely with the...
by McDermott + Bull | Jun 2, 2021 | Ken Dropiewski, White Paper
THE NEW NORMAL: WHAT BUSINESS TRAVEL WILL LOOK LIKE FOR EXECUTIVES Over the past six months, I’ve had the opportunity to speak with executives in the life science and medtech space about the reduction in business travel due to the pandemic. We talked about what it has...
by McDermott + Bull | May 17, 2021 | Chris Bull, Ken Dropiewski, Placement Announcement
McDermott + Bull has successfully placed Navesh Kandiyil as the Vice President of Respiratory Business + Clinical Programs and Tom Hendrix as Market Vice President for Apria Healthcare. As the Vice President of Respiratory Business + Clinical Programs, Navesh will...
